Dock2 in the development of inflammation and cancer.
- Published in:
- European Journal of Immunology, 2018, v. 48, n. 6, p. 915, doi. 10.1002/eji.201747157
- By:
- Publication type:
- Article
Works matching AU Liangmei He
Results: 15
1
2
Interferon regulatory factor 7 alleviates the experimental colitis through enhancing IL-28A-mediated intestinal epithelial integrity.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05673-y
- By:
- Publication type:
- Article
3
A DNA Vaccine Encoding a Codon-Optimized Human Papillomavirus Type 16 E6 Gene Enhances CTL Response and Anti-tumor Activity.
- Published in:
- Journal of Biomedical Science, 2006, v. 13, n. 4, p. 481, doi. 10.1007/s11373-006-9086-6
- By:
- Publication type:
- Article
4
Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies.
- Published in:
- Journal of Biomedical Science, 2005, v. 12, n. 5, p. 689, doi. 10.1007/s11373-005-9012-3
- By:
- Publication type:
- Article
5
A DNA Vaccine Co-Expressing Antigen and an Anti-Apoptotic Molecule Further Enhances the Antigen-Specific CD8+ T-Cell Immune Response.
- Published in:
- Journal of Biomedical Science, 2004, v. 11, n. 4, p. 493, doi. 10.1159/000077899
- By:
- Publication type:
- Article
6
Repeated DNA Vaccinations Elicited Qualitatively Different Cytotoxic T Lymphocytes and Improved Protective Antitumor Effects.
- Published in:
- Journal of Biomedical Science, 2002, v. 9, n. 6, p. 675, doi. 10.1007/BF02254996
- By:
- Publication type:
- Article
7
DNA Vaccines Encoding Ii-PADRE Generates Potent PADRE-specific CD4<sup>+</sup> T-Cell Immune Responses and Enhances Vaccine Potency.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 6, p. 1211, doi. 10.1038/sj.mt.6300121
- By:
- Publication type:
- Article
8
Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-Expressing sindbis virus replicon particles
- Published in:
- Molecular Therapy, 2003, v. 8, n. 4, p. 559, doi. 10.1016/S1525-0016(03)00238-7
- By:
- Publication type:
- Article
9
Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8<sup>+</sup> T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093162
- By:
- Publication type:
- Article
10
Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056912
- By:
- Publication type:
- Article
11
Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+ T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035141
- By:
- Publication type:
- Article
12
Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen.specific CD8+ T.cell immune responses and antitumor effects without adjuvant.
- Published in:
- Cell & Bioscience, 2016, p. 1, doi. 10.1186/s13578-016-0083-9
- By:
- Publication type:
- Article
13
Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways.
- Published in:
- European Journal of Immunology, 2004, v. 34, n. 7, p. 1892, doi. 10.1002/eji.200424877
- By:
- Publication type:
- Article
14
DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
- Published in:
- Cellular & Molecular Life Sciences, 2021, v. 78, n. 24, p. 8261, doi. 10.1007/s00018-021-04013-3
- By:
- Publication type:
- Article
15
Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis.
- Published in:
- Cellular & Molecular Life Sciences, 2017, v. 74, n. 13, p. 2395, doi. 10.1007/s00018-017-2477-1
- By:
- Publication type:
- Article